The "Tap-Drain" model of central serous chorioretinopathy: Mechanistic staging and a Corrective Action-Preventative Action-based framework for disease modification.

Abstract

Central serous chorioretinopathy (CSCR) has traditionally been regarded as a self-limiting disorder and classified using duration- or phenotype-based frameworks. Accumulating clinical and imaging evidence, however, suggests that CSCR is a recurrent disorder in which choroidal haemodynamic abnormalities and retinal pigment epithelium (RPE) dysfunction interact to determine long-term structural and functional outcomes. We synthesize current advances in choroidal physiology and multimodal imaging to propose the Tap-Drain model, a physiology-based conceptual framework that reconceptualizes CSCR as a disorder of outer retinal fluid homeostasis. Within this framework, fluid entry ("tap") is proposed to arise predominantly from choroidal haemodynamic abnormalities, including vascular hyperpermeability and impaired venous drainage, whereas disease expression may also be influenced by regional variability in RPE functional reserve. Fluid clearance ("drain") is mediated by the RPE, and impaired RPE function may reduce its capacity to compensate for increased choroidal inflow, resulting in persistent or recurrent subretinal fluid (SRF). We further propose a mechanistic staging system and a Corrective Action-Preventive Action (CAPA) framework that aligns management with the predominant imbalance between fluid entry and clearance. By distinguishing tap-dominant, drain-stressed, and drain-failure phenotypes, the framework shifts treatment goals beyond episodic SRF resolution toward recurrence prevention, preservation of retinal structure, and maintenance of long-term visual function. Although biologically plausible and clinically intuitive, the Tap-Drain model remains a conceptual framework that requires prospective clinical validation before its prognostic and therapeutic implications can be considered established.